A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
about
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell linesTwo novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas.EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.Role of trastuzumab in the management of HER2-positive metastatic breast cancer.Identifying responders to trastuzumab therapy in breast cancer.Evaluation of HER2 in breast cancer: reality and expectations.Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues.
P2860
Q24293655-DD6EBA48-EA1E-4AC6-A164-9BD6DA2E197CQ33658544-9F8806D7-43BA-4ED4-A6A8-17FFE177DA36Q35984457-47B902D0-91D5-4AA7-97B9-0353A1B20EB5Q37206247-27EF5B87-2126-46B9-814D-160280D6DECEQ37355370-B00A3391-2A71-4844-A496-FAEBF0DCFDDBQ37889967-EBB55A90-9F79-4B59-B99C-1695F9147933Q38089837-171836C0-2A89-4211-90BE-57B3790E2003Q38111772-D65C5353-6978-4980-BCBD-3CB74E661AE2
P2860
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A modified Trastuzumab antibod ...... verexpression in breast cancer
@ast
A modified Trastuzumab antibod ...... verexpression in breast cancer
@en
type
label
A modified Trastuzumab antibod ...... verexpression in breast cancer
@ast
A modified Trastuzumab antibod ...... verexpression in breast cancer
@en
prefLabel
A modified Trastuzumab antibod ...... verexpression in breast cancer
@ast
A modified Trastuzumab antibod ...... verexpression in breast cancer
@en
P2093
P2860
P50
P356
P1476
A modified Trastuzumab antibod ...... verexpression in breast cancer
@en
P2093
F Montemurro
G Bussolati
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602507
P407
P577
2005-04-01T00:00:00Z